We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 51.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.882%)
Open: 52.50
High: 52.50
Low: 52.50
Prev. Close: 52.50
BVT Live PriceLast checked at -
Baronsmead Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

25 May 2018 07:00

RNS Number : 2570P
Baronsmead Venture Trust PLC
25 May 2018
 

Baronsmead Venture Trust plc

Half-Yearly report for the six months ended

31 March 2018

 

The Directors announce the unaudited half-yearly financial report for the six months to 31 March 2018.

 

Copies of the half-yearly report can be obtained from the following website: www.baronsmeadvcts.co.uk.

 

Our Investment Objective

 

Baronsmead Venture Trust is a tax efficient listed company which aims to achieve long-term investment returns for private investors, including tax-free dividends.

 

Investment Policy

 

· To invest primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

· Investments are made selectively across a range of sectors in companies that have the potential to grow and enhance their value.

 

Dividend Policy

 

The Board of Baronsmead Venture Trust aims to sustain a minimum annual dividend level at an average of 6.5p per ordinary share, mindful of the need to maintain net asset value. The ability to meet these twin objectives depends significantly on the level and timing of profitable realisations and cannot be guaranteed. There will be variations in the amount of dividends paid year on year.

 

Shareholder choice

 

The Board wishes to provide shareholders with a number of choices that enable them to utilise their investment in Baronsmead Venture Trust in ways that best suit their personal investment and tax planning requirements and in a way that treats all shareholders equally.

 

· Fund raising | From time to time the Company seeks to raise additional funds by issuing new shares at a premium to the latest published net asset value to account for issue costs. This enables shareholders seeking additional investments to do so with taxation relief.

 

· Dividend Reinvestment Plan | The Company offers a Dividend Reinvestment Plan which enables shareholders to purchase additional shares through the market in lieu of cash dividends. Approximately 770,000 shares were bought in this way during the six months to 31 March 2018.

 

· Buy back of shares | From time to time the Company buys its own shares through the market in accordance with its share price discount policy. Subject to certain conditions, the Company seeks to maintain a mid market share price discount of approximately 5 per cent. to net asset value.

 

· Secondary market | The Company's shares are listed on the London Stock Exchange and can be bought or sold by shareholders using a stockbroker or authorised share dealing service in the same way as shares of any other listed company. Approximately 505,000 shares were bought by investors in the Company's existing shares in the six months to 31 March 2018.

 

Financial Headlines

 

· 394.7p - NAV total return to shareholders for every 100.0p invested at launch.

 

· £21m - Funds raised in the period (before costs).

 

· (0.4)% - Net asset value ("NAV") per share decreased 0.4 per cent. to 88.01p in the six months to 31 March 2018.

 

Cash returned to shareholders by date of investment 

 

The table below shows the cash returned to shareholders that invested in Baronsmead Venture Trust plc dependent on their subscription cost, including the income tax available to be reclaimed on the subscription.

 

Year subscribed

Cash invested

 (p)

Income tax reclaim

(p)

 

Net cash invested

(p)

Cumulative dividends

paid

 (p)

Return on cash invested (%)

1998 (April)

100.0

20.0

80.0

146.9

166.9

1999 (May)

102.0

20.4

81.6

143.4

160.6

2000 (February)

137.0

27.4

109.6

140.2

122.3

2000 (March)

130.0

26.0

104.0

140.2

127.9

2004 (October) - C shares*

100.0

40.0

60.0

96.6

136.6

2009 (April)

91.6

27.5

64.1

79.0

116.2

2012 (December)

111.8

33.5

78.3

53.5

77.9

2014 (March)

103.8

31.1

72.7

36.0

64.7

2016 (February)

102.8

30.8

72.0

21.5

50.9

2017 (October)

94.8

28.4

66.4

3.5

33.7

 

* Share dividend calculated using conversion ratio of 0.9657, which is the rate the C shares were converted into ordinary shares.

 

 

Chairman's Statement 

 

The six months to 31 March 2018 saw two successful realisations from our unquoted investments and a period of relative stability in the performance and valuation of the portfolio as a whole, despite some market volatility.

 

During the period, the Company successfully raised £21m (before costs) through an offer for subscription which became fully subscribed on 3 November 2017.

 

Results

During the six months to 31 March 2018, the Company's NAV per share decreased 0.4 per cent from 88.4p to 88.0p after the payment of a final dividend of 3.5p per share on 2 March 2018.

 

 

Pence per ordinaryshare

NAV as at 1 October 2017

(after deducting the final dividend of 3.5p)

88.4

Valuation decrease (0.4 per cent)

(0.4)

NAV as at 31 March 2018

88.0

 

The decrease in NAV of 0.4 per cent was primarily the result of a period of uncertainty in the quoted markets and a reduction in value of our unquoted holding in In the Style Fashion, which was offset by steady progress being made by most of the more mature unquoted investments.

 

Over the six months to 31 March 2018, our unquoted investments delivered an increase in their valuations of

2.0 per cent after allowing for provisions on some underperforming investments. There has been an increased period of weakness in quoted markets, particularly in the second half of the period under review and the value of our AIM-traded and other listed investments decreased by 2.5 per cent. However, our inves ment in LF Livingbridge UK Micro Cap Fund ("Micro Cap Fund"), increased by 4.5 per cent and our new investment, made in November 2017, in LF Livingbridge UK Multi Cap Income Fund ("Multi Cap Income Fund") increased by 1.3 per cent, demonstrating some resilience in this market.

 

Portfolio Review

 

At 31 March 2018, the Company's investment portfolio was valued at £136m and comprised investments in 70 unquoted and AIM-traded companies. The Company's investments in the Micro Cap Fund and Multi Cap Income Fund provides investment exposure to an additional 55 AIM-traded and fully listed companies.

 

Investment and Divestments

 

The Company's investments and divestments during the period are set out in the tables below.

 

As I have discussed previously, the new VCT rules introduced in November 2015 and further amended in the Autumn Budget in 2017, have required the Investment Manager to adapt its investment strategy to focus on the provision of development capital to younger companies to enable them to grow their businesses organically rather than through acquisition.

 

The Manager, with the support of the Board, took time to consider how best to deploy funds into these earlier stage companies, and following the seven new investments made in the 2017 financial year, I am now pleased to report that the Company made three new investments totalling £1.2m and two follow-on investments totalling £0.7m in the six months to 31 March 2018. The new investments included PCI-PAL, a secure cloud payment solutions provider, Beeks Financial Cloud Group, a provider of specialist hosting and connectivity solutions to financial institutions and Fusion Antibodies, a specialist healthcare services provider. Follow on investments were made into SilkFred, a fast fashion e-tailer and CloudCall Group, a cloud based telephony platform.

 

During the period, a total of £13.1m was realised from the full and partial sale of both unquoted and quoted investments. Full realisations included one of our longest standing unquoted investments, Crew Clothing, a clothing brand specialising in active, outdoor and casual wear resulting in a return on cost of 2.3x and, Eque2, an unquoted investment which provides software to the construction industry at 3.0x cost. Regrettably, one quite recent unquoted investment, In the Style Fashion, has been fully provided for in the period.

 

Dividends

 

A final dividend of 3.5p per share was paid on 2 March 2018, having been approved at the AGM on 21 February 2018.

 

The Board aims to sustain a minimum annual dividend level at an average of 6.5p per ordinary share and going forward, the Board will wherever possible, seek to pay two dividends to shareholders in each calendar year. I must of course remind shareholders that the payment date and amount of future dividends depends significantly on the level and timing of profitable realisations and cannot be guaranteed and inevitably, there will be variations in the amounts and dates on which dividends are paid.

 

Fundraising

 

The Board will consider whether to raise new funds in the 2018/19 tax year which will be determined by the Company's cashflow and its anticipated requirements to fund new investments over the next two years. The Board appreciates that shareholders would like as much notice as possible of its fundraising intentions so that they can plan their financial affairs accordingly. Ordinarily, the Board seeks to raise funds during January and February, having informed shareholders of its fundraising intentions in November, when its annual results are published or earlier if practicable.

 

VCT legislation and policy review

 

As discussed at our AGM in February, following the Patient Capital Review in the summer of 2017, legislative changes to VCTs included in the 2017 Autumn Budget were limited and were primarily to ensure that VCT funding was appropriately targeted. In summary, investment rules continue to seek to ensure that VCTs invest in younger, earlier stage companies and the funding is used for organic growth and development of those companies. Importantly, there was no change to the tax incentives for investors.

 

Overall, in our opinion, the 2017 Patient Capital Review and Autumn Budget were positive for the VCT industry and both your Board and the Investment Manager are hopeful that the status quo will now remain for a number of years.

 

Board succession

 

Christina McComb, who had been a non-executive director of Baronsmead VCT 2 since 2011, decided to retire from the Board in December last year in order to focus on her other business interests. We would like to thank Christina for her contribution to the Company and wish her all the best for the future.

 

I am delighted to welcome Susannah Nicklin to the Board. Susannah is a former non-executive director of Baronsmead VCT plc, with 20 years of experience in executive roles at Goldman Sachs and Alliance Bernstein in the US, Australia and the UK. She has also worked in the social impact private equity sector with Bridges Ventures, the Global Impact Investing Network and Impact Ventures UK. Susannah is senior independent director of Pantheon International plc and a non-executive director of City of London Investment

Group plc and Amati AIM VCT plc.

 

Outlook

 

While there are continued negotiations surrounding Brexit and ongoing political uncertainty, the UK economy has remained relatively resilient, although we have witnessed some declines in markets since the beginning of the year. Despite this, the Company's portfolio is diverse and continues to make steady progress.

 

The Board is mindful that the new VCT rules have refocussed VCTs towards younger earlier stage companies which may be generally less resilient to economic shocks and downturns and inevitably therefore, may have a higher risk of possible failure. However, our Manager has over 20 years of experience investing in smaller companies and, while the new investments are expected to introduce greater variations of returns, the Company still has a diverse portfolio of older, more established businesses with low levels of debt. It is these investments which will determine returns and liquidity over the medium term and will provide the stability required as the newer, earlier stage portfolio is allowed to develop.

 

 

Peter Lawrence

Chairman

25 May 2018

 

 

 

Investment Diversification at 31 March 2018

 

 

Sector by value

 

Percentage

 

 

Business Services

33%

Consumer Markets

12%

Healthcare & Education

18%

Technology, Media & Telecommunications ("TMT")

37%

 

 

Total assets by value

 

Percentage

 

 

Unquoted - loan stock

16%

Unquoted - equity

9%

AIM & collective investment vehicles

75%

 

 

Time investments held by value

 

Percentage

 

 

Less than 1 year

3%

Between 1 and 3 years

14%

Between 3 and 5 years

34%

Greater than 5 years

49%

 

Investments in the period

Company

Location

Sector

Activity

Book cost

£'000

Unquoted investments

Follow on

SilkFred Limited

London

Consumer Markets

Online fashion market place

225

Total unquoted investments

225

AIM-traded investments

New

Fusion Antibodies plc

Belfast

Healthcare & Education

Development of antibodies for both therapeutic and diagnostic applications

450

PCI-PAL plc

London

TMT*

Secure payment services provider

405

Beeks Financial Cloud Group plc

Renfrewshire

TMT*

Cloud hosting services for the financial trading sector

337

Follow on

 

 

 

 

CloudCall Group plc

Leicestershire

TMT*

Cloud based telephony platform

450

Total AIM-traded investments

1,642

Total investments in the year

1,867

 

* Technology, Media & Telecommunications ("TMT").

 

Realisations in the period

 

Company

 

 

First

investment

date

Proceeds

£'000

Overall

multiple

return*

Unquoted realisations

Crew Clothing Holdings Limited

 

Trade sale

Nov 06

5,362

2.3

Eque 2 Limited

 

Trade sale

Apr 13

4,197

3.0

Kirona Limited

 

Partial loan repayment

Dec 14

983

1.2

Xention Pharma Limited

 

Write off

Jul 05

0

0.0

Total unquoted realisations

 

 

 

10,542

 

AIM-traded realisations

EG Solutions plc

 

Scheme of arrangement

May 05

2,155

1.5

Plant Impact plc

 

Scheme of arrangement

Feb 15

403

0.3

Ubisense Group plc

 

Market sale

Jun 11

19

0.2

Total AIM-traded realisations

 

 

 

2,577

 

Total realisations in the year

 

 

 

13,119

 

Proceeds at time of realisation including interest.

 

* Includes interest/dividends received, loan note redemptions and partial realisations accounted for in prior periods.

 

Deferred consideration of £7,000 was received in respect of Kingsbridge Risk Solutions which had been sold in a prior period.

 

 

Independent Review Report to Baronsmead Venture Trust plc

 

Conclusion

 

We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 31 March 2018 which comprises the Condensed Income Statement, Condensed Statement of Changes in Equity, Condensed Balance Sheet, Condensed Statement of Cash Flows and the related explanatory notes.

 

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 31 March 2018 is not prepared, in all material respects, in accordance with FRS 104 Interim Financial Reporting and the Disclosure Guidance and Transparency Rules ("the DTR") of the UK's Financial Conduct Authority ("the UK FCA").

 

Scope of Review

 

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Auditing Practices Board for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. We read the other information contained in the half-yearly financial report and consider whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

 

A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Directors' responsibilities

 

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the DTR of the UK FCA.

 

As disclosed in note 1, the annual financial statements of the Company are prepared in accordance with UK Accounting Standards and applicable law (UK Generally Accepted Accounting Practice), including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland. The directors are responsible for preparing the condensed set of financial statements included in the half-yearly financial report in accordance with FRS 104 Interim Financial Reporting.

 

Our responsibility

 

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.

 

The purpose of our review work and to whom we owe our responsibilities

 

This report is made solely to the Company in accordance with the terms of our engagement to assist the Company in meeting the requirements of the DTR of the UK FCA. Our review has been undertaken so that we might state to the Company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company for our review work, for this report, or for the conclusions we have reached.

 

John Waterson

for and on behalf of KPMG LLP

Chartered Accountants

Saltire Court

20 Castle Terrace

Edinburgh EH1 2EG

25 May 2018

 

 

Responsibility Statement of the Directors in respect of the Half-Yearly Financial Report

 

We confirm that to the best of our knowledge:

● the condensed set of financial statements has been prepared in accordance with FRS 104 Interim Financial Reporting

● the interim management report includes a fair review of the information required by:

 

a) DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

b) DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period; and any changes in the related party transactions described in the last annual report that could do so.

 

On behalf of the Board

 

Peter Lawrence

Chairman

25 May 2018

Condensed Income Statement (unaudited)

For the six months to 31 March 2018

 

 

 

Six months to31 March 2018

Six months to31 March 2017

Year to30 September 2017

 

Notes

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

 

Capital

£'000

 

Total

£'000

 

Revenue

£'000

 

Capital

£'000

 

Total

£'000

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealised (losses)/gains on movement in fair value of investments

7

-

(12)

(12)

-

 

8,161

 

8,161

 

-

 

15,108

 

15,108

Realised (losses)/gains on disposal of investments

7

-

(2,542)

(2,542)

-

 

64

 

64

 

-

 

134

 

134

Income

 

3,699

-

3,699

1,037

 

-

 

1,037

 

2,569

 

-

 

2,569

Investment management fee and performance fee

 

(410)

(1,230)

(1,640)

(370)

 

(1,370)

 

(1,740)

 

(750)

 

(2,955)

 

(3,705)

Other expenses

 

(338)

-

(338)

(284)

 

-

 

(284)

 

(501)

 

-

 

(501)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit/(loss) before taxation

 

2,951

(3,784)

(833)

383

 

6,855

 

7,238

 

1,318

 

12,287

 

13,605

Taxation

 

(291)

291

-

-

 

-

 

-

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit/(loss) for the period, being total comprehensive income for the period

 

2,660

(3,493)

(833)

383

 

6,855

 

7,238

 

1,318

 

12,287

 

13,605

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Return per ordinary share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and Diluted

2

1.39p

(1.83p)

(0.44p)

0.22p

 

3.96p

 

4.18p

 

0.76p

 

7.08p

 

7.84p

 

All items in the above statement derive from continuing operations.

 

There are no recognised gains and losses other than those disclosed in the Income Statement.

 

The revenue column of the Income Statement includes all income and expenses. The capital column accounts for the realised and unrealised profit or loss on investments and the proportion of the management fee charged to capital.

 

The total column of this statement is the unaudited Statement of Total Comprehensive Income of the Company prepared in accordance with the Financial Reporting Standard ("FRS"). The supplementary revenue return and capital return columns are prepared in accordance with the Statement of Recommended Practice issued in November 2014 and updated in January 2017 and February 2018 by the Association of Investment Companies ("AIC SORP").

 

 

Condensed Statement of Changes in Equity (unaudited)

 

For the six months to 31 March 2018

 

 

 

 

Non-distributable reserves

Distributable reserves

Total

£'000

Notes

Called-up share capital

£'000

Share

premium £'000

Revaluation

reserve

£'000

Capital

reserve £'000

Revenue

reserve

£'000

At 1 October 2017

 

18,412

-

41,352

97,963

1,275

159,002

Share premium cancellation costs

 

-

-

-

2

-

2

(Loss)/profit after taxation

 

-

-

(3,317)

(176)

2,660

(833)

Net proceeds of share issue & share buybacks

4

2,216

18,154

-

(1,533)

-

18,837

Dividends paid

6

-

-

-

(5,864)

(932)

(6,796)

At 31 March 2018

 

20,628

18,154

38,035

90,392

3,003

170,212

 

 

For the six months to 31 March 2017

 

 

Non-distributable reserves

Distributable reserves

Total

£'000

Notes

Called-up share capital

£'000

Share

premium £'000

Revaluation

reserve

£'000

Capital

reserve £'000

Revenue

reserve

£'000

At 1 October 2016

 

18,412

96,515

25,238

10,089

304

150,558

Profit/(loss) after taxation

 

 

 

8,196

(1,341)

383

7,238

Net proceeds of sale of shares from treasury

4

-

-

-

1,033

-

1,033

Dividends paid

6

-

-

-

(4,862)

(347)

(5,209)

At 31 March 2017

 

18,412

96,515

33,434

4,919

340

153,620

 

 

For the year to 30 September 2017

 

 

Non-distributable reserves

Distributable reserves

Total

£'000

Notes

Called-up share capital

£'000

Share

premium £'000

Revaluation

reserve

£'000

Capital

reserve £'000

Revenue

reserve

£'000

At 1 October 2016

 

18,412

96,515

25,238

10,089

304

150,558

Cancellation of share premium

 

-

(96,515)

-

96,515

-

-

Share premium cancellation costs

 

-

-

-

(31)

-

(31)

Profit/(loss) after taxation

 

-

-

16,114

(3,827)

1,318

13,605

Net proceeds of share buybacks & sale of shares from treasury

4

-

-

-

79

-

79

Dividends paid

6

-

-

-

(4,862)

(347)

(5,209)

At 30 September 2017

 

18,412

-

41,352

97,963

1,275

159,002

 

 

Condensed Balance Sheet (unaudited)

As at 31 March 2018

 

 

Notes

 

As at

31 March

2018

£'000

As at 31 March

2017

£'000

As at30 September 2017

£'000

Fixed assets

 

 

 

 

Unquoted investments

7

42,219

50,908

51,644

Traded on AIM

7

67,158

67,342

69,811

Collective investment vehicles

7

60,692

32,092

38,675

 

 

 

 

 

Investments

7

170,069

150,342

160,130

 

 

 

 

 

Current assets

 

 

 

 

Debtors

 

519

174

175

Cash at bank and on deposit

 

653

4,329

409

 

 

1,172

4,503

584

 

 

 

 

 

Creditors (amounts falling due within one year)

 

(1,029)

(1,225)

(1,712)

 

 

 

 

 

Net current assets/(liabilities)

 

143

3,278

(1,128)

 

 

 

 

 

Net assets

 

170,212

153,620

159,002

 

 

 

 

 

Capital and reserves

 

 

 

 

Called-up share capital

 

20,628

18,412

18,412

Share premium

 

18,154

96,515

-

Capital reserve

 

90,392

4,919

97,963

Revaluation reserve

7

38,035

33,434

41,352

Revenue reserve

 

3,003

340

1,275

 

 

 

 

 

Equity shareholders' funds

 

170,212

153,620

159,002

 

 

 

 

As at

31 March

2018

£'000

As at 31 March

2017

£'000

As at30 September 2017

£'000

 

 

 

 

 

 

 

 

Basic net asset value per share

88.01

p

88.23

p

91.90

p

Number of ordinary shares in circulation

193,406,404

 

174,120,866

 

173,020,866

 

 

Condensed Statement of Cash Flows (unaudited)

For the six months to 31 March 2018

 

 

Sixmonths to31 March 2018

£'000

Sixmonths to31 March2017

£'000

Year

to30 September 2017

£'000

 

 

 

 

Net cash inflow/(outflow) from operating activities

1,123

(798)

(990)

Net cash outflow from investing activities

(12,897)

(13,856)

(16,627)

Equity dividends paid

(6,796)

(5,209)

(5,209)

 

 

 

 

Net cash outflow before financing activities

(18,570)

(19,863)

(22,826)

Net cash inflow from financing activities

18,814

2,601

1,644

 

 

 

 

Increase/(decrease) in cash

244

(17,262)

(21,182)

 

 

 

 

Reconciliation of net cash flow to movement in net cash

 

 

 

Increase/(decrease) in cash

244

(17,262)

(21,182)

Opening cash position

409

21,591

21,591

 

 

 

 

Closing cash at bank and on deposit

653

4,329

409

 

 

 

 

Reconciliation of (loss)/profit before taxation to net cash inflow/(outflow) from operating activities

 

 

 

(Loss)/profit before taxation

(833)

7,238

13,605

Losses/(gains) on investments

2,554

(8,225)

(15,242)

Changes in working capital and other non-cash items

(598)

189

647

 

 

 

 

Net cash inflow/(outflow) from operating activities

1,123

(798)

(990)

 

 

 

 

 

Notes

 

1. The condensed financial statements for the six months to 31 March 2018 comprise the unaudited statements set out above together with the related notes below. The Company applies FRS 102 and the AIC's Statement of Recommended Practice issued in November 2014 and updated in January 2017 and February 2018 ('the SORP') for its annual financial statements. The condensed financial statements for the six months to 31 March 2018 have therefore been prepared in accordance with FRS 104 'Interim Financial Reporting' and the principles of the SORP. They have been prepared on a going concern basis. The accounts have been prepared on the same basis as the accounting policies set out in the Company's Annual Report and Financial Statements for the year ended 30 September 2017.

 

The financial information contained in this half-yearly financial report does not constitute statutory accounts as defined in sections 434 - 436 of the Companies Act 2006. The information for the year to 30 September 2017 has been extracted from the latest published audited financial statements, which have been filed with the Registrar of Companies. The report of the auditor for the audited financial statements for the year to 30 September 2017 was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498 (2) or (3) of the Companies Act 2006. No statutory accounts in respect of any period after 30 September 2017 have been reported on by the Company's auditors or delivered to the Registrar of Companies.

 

2. Return per share is based on a weighted average of 190,645,869 ordinary shares in issue (31 March 2017 - 173,351,635 ordinary shares; 30 September 2017 - 173,485,578 ordinary shares).

 

3. Earnings for the first six months to 31 March 2018 should not be taken as a guide to the results of the full financial year to 30 September 2018.

 

4. During the six months to 31 March 2018, the Company issued 22,160,538 shares at net proceeds of £20,370,000 (including costs). During the same period, the Company purchased 1,775,000 shares to be held in treasury at a cost of £1,533,000. At 31 March 2018, the Company held 12,878,819 ordinary shares in treasury. Shares may be sold out of treasury below Net Asset Value as long as the discount at issue is narrower than the average discount at which the shares were bought into treasury.

 

5. Excluding treasury shares, there were 193,406,404 ordinary shares in issue at 31 March 2018 (31 March 2017 - 174,120,866 ordinary shares; 30 September 2017 - 173,020,866 ordinary shares).

 

6. The final dividend in relation for the year ended 30 September 2017 of 3.50p per share (3.02p capital, 0.48p revenue) was paid on 2 March 2018 to shareholders on the register on 2 February 2018. The ex-dividend date was 1 February 2018. During the year to 30 September 2017, the Company paid an interim dividend on 31 March 2017 of 3.00p per share (2.80p capital, 0.20p revenue).

 

7. All investments are initially recognised and subsequently measured at fair value. Changes in fair value are recognised in the Income Statement.

The methods of fair value measurement are classified into a hierarchy based on reliability of the information used to determine the valuation.

Level 1 - Fair value is measured based on quoted prices in an active market.

Level 2 - Fair value is measured based on directly observable current market prices or indirectly being derived from market prices.

Level 3 - Fair value is measured using a valuation technique that is not based on data from an observable market.

 

 

Level 1

Level 2

Level 3

 

 

Traded

on AIM

£'000

Collective

investment

vehicles

£'000

 

Traded

On AIM

£'000

Unquoted

£'000

Total

£'000

Opening book cost

48,755

27,781

2,315

39,927

118,778

Opening unrealised appreciation/(depreciation)

19,965

10,894

(1,224)

11,717

41,352

Opening valuation

68,720

38,675

1,091

51,644

160,130

Movements in the period:

 

 

 

 

 

Transfer between levels

1,267

-

(1,267

-

-

Purchases at cost

1,642

22,730

-

225

24,597

Sale - proceeds

(2,577)

(1,800)

-

(7,727)

(12,104)

- realised losses on sales

(598)

-

-

(1,944)

(2,542)

Unrealised gains realised during the period

599

-

-

2,706

3,305

(Decrease)/increase in unrealised appreciation

(3,237)

1,087

1,518

(2,685)

(3,317)

Closing valuation

65,816

60,692

1,342

42,219

170,069

Closing book cost

49,088

48,711

1,048

33,187

132,034

Closing unrealised appreciation

16,728

11,981

294

9,032

38,035

Closing valuation

65,816

60,692

1,342

42,219

170,069

Equity shares

65,816

-

1,342

15,281

82,439

Loan notes

-

-

-

26,938

26,938

Collective investment vehicles

-

60,692

-

 

60,692

Closing valuation

65,816

60,692

1,342

42,219

170,069

 

CentralNic Group plc has been changed to a Level 3 investment due to a suspension of trading during the period. TLA Worldwide plc has been changed to a Level 1 investment due to a lift on the suspension of trading during the period.

 

There has been no significant change in the risk analysis as disclosed in the Company's Annual Report and Accounts to 30 September 2017.

 

8. The Company has one reportable segment being investing in primarily a portfolio of UK growth businesses, whether unquoted or traded on AIM.

 

9. Copies of the half-yearly financial report have been made available to shareholders and are available from the Registered Office of the Company at 100 Wood Street, London EC2V 7AN.

 

 

Principal Risks and Uncertainties

 

The Company's financial instruments consist of equity and fixed interest investments, cash balances and liquid resources. Its principal risks are therefore market risk, credit risk and liquidity risk. Other risks faced by the Company include loss of approval as a Venture Capital Trust, legislative, investment performance, economic, political and other external factors, regulatory and compliance and operational risks. These risks, and the way in which they are managed, are described in more detail in the Principal Risks & Uncertainties table within the Strategic Report section in the Company's Report and Financial Statements for the year to 30 September 2017. The Company's principal risks and uncertainties have not changed materially since the date of that report.

 

Related Parties

 

Livingbridge VC LLP ('the Manager') manages the investments of the Company. The Manager also provides or procures the provision of secretarial, administrative and custodian services to the Company. Under the management agreement, the Manager receives a fee of 2.0 per cent per annum of the net assets of the Company. This is described in more detail under the heading 'The management agreement' within the Strategic Report in the Company's Annual Report and Financial Statements for the year to 30 September 2017. During the period the Company has incurred management fees of £1,640,000 (31 March 2017 - £1,480,000; 30 September 2017 - £3,001,000) and secretarial fees of £72,000 (31 March 2017 - £72,000; 30 September 2017 - £143,000) payable to the Manager. No performance fee has been accrued at 31 March 2018 (31 March 2017 - £260,000; 30 September 2017 - £704,000). This is described in more detail under the heading 'Performance fees' within the Strategic Report in the Company's Annual Report and Financial Statements for the year to 30 September 2017.

 

Going Concern

 

After making enquiries, and bearing in mind the nature of the Company's business and assets, the Directors consider that the Company has adequate resources to continue in operational existence for the foreseeable future. In arriving at this conclusion the Directors have considered the liquidity of the Company and its ability to meet obligations as they fall due for a period of at least twelve months from the date that these financial statements were approved. As at 31 March 2018 the Company held cash and investments in readily realisable securities with a value of £34,413,000. Cash flow projections have been reviewed and show that the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of the share buyback programme and dividend policy. The Company has no external loan finance in place and therefore is not exposed to any gearing covenants.

 

 

Corporate Information

 

Directors

Peter Lawrence (Chairman)

Valerie Marshall

Les Gabb

Susannah Nicklin

 

Secretary

Livingbridge VC LLP

 

Registered Office

100 Wood Street

London EC2V 7AN

 

Investment Manager

Livingbridge VC LLP

100 Wood Street

London EC2V 7AN

020 7506 5717

 

Registered Number

03504214

 

Registrars and Transfer Office

Computershare Investor Services PLC

The Pavilions

Bridgwater Road

Bristol BS99 6ZZ

Tel: 0800 923 1533

 

Brokers

Panmure Gordon & Co

One New Change

London EC4M 9AF

Tel: 020 7886 2500

 

Auditors

KPMG LLP

Saltire Court

20 Castle Terrace

Edinburgh EH1 2EG

 

Solicitors

Dickson Minto

Broadgate Tower

20 Primrose Street

London EC2A 2EW

 

VCT Status Adviser

PricewaterhouseCoopers LLP

1 Embankment Place

London WC2N 6RH

 

Website

www.baronsmeadvcts.co.uk

 

 

 

National Storage Mechanism

 

A copy of the Half-Yearly Report will be submitted shortly to the National Storage Mechanism ("NSM") and will be available for inspection at the NSM, which is situated at: www.morningstar.co.uk/uk/NSM.

 

 

END

 

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on this announcement (or any other website) is incorporated into, or forms part of, this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR LLFFRETISFIT
Date   Source Headline
29th Apr 20243:30 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 202411:00 amRNSShare Allotment,Total Voting Rights,Close of Offer
19th Mar 20245:37 pmRNSClose of Offer to New Applications
18th Mar 20244:46 pmRNSDirector/PDMR Shareholding
15th Mar 20244:04 pmRNSTransaction in Own Shares
6th Mar 20243:00 pmRNSNet Asset Value(s)
6th Mar 20241:22 pmRNSResult of AGM
1st Mar 202410:20 amRNSTotal Voting Rights
15th Feb 20242:05 pmRNSDirector/PDMR Shareholding
15th Feb 20242:00 pmRNSAllotment of Shares and Total Voting Rights
7th Feb 202410:00 amRNSNet Asset Value(s)
2nd Feb 20248:00 amRNSIntention to Utilise Over-allotment Facility
1st Feb 20245:18 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 202412:01 pmRNSDirector/PDMR Shareholding
30th Jan 202412:00 pmRNSDirector/PDMR Shareholding
26th Jan 20242:30 pmRNSAllotment of Shares and Total Voting Rights
24th Jan 20245:00 pmRNSNet Asset Value(s)
24th Jan 20244:00 pmRNSNet Asset Value(s)
22nd Jan 20243:00 pmRNSOffer Update Extension of Early Bird Discount Date
19th Jan 20242:35 pmRNSIssue of Supplementary Prospectus
5th Jan 202411:36 amRNSChange of allotment date - correction
4th Jan 20243:45 pmRNSChange of allotment date
2nd Jan 202411:00 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20235:40 pmRNSTransaction in Own Shares
6th Dec 20231:30 pmRNSNet Asset Value(s)
24th Nov 20231:27 pmRNSPublication of a Prospectus/Offer for Subscription
22nd Nov 20237:00 amRNSCompliance with Market Abuse Regulation ("MAR")
14th Nov 202310:01 amRNSUpdate on Offer for Subscription
6th Nov 20234:01 pmRNSNet Asset Value(s)
27th Oct 20231:30 pmRNSNet Asset Value(s)
19th Oct 20234:51 pmRNSDirectorate Change
12th Oct 202311:22 amRNSAppointment of Non-Executive Director
2nd Oct 20234:00 pmRNSTotal Voting Rights
28th Sep 20235:52 pmRNSTransaction in Own Shares
12th Sep 20236:28 pmRNSTransaction in Own Shares - Replacement
12th Sep 20235:20 pmRNSTransaction in Own Shares
5th Sep 202311:00 amRNSIntention to Fundraise
4th Aug 20234:00 pmRNSNet Asset Value(s)
1st Aug 20231:52 pmRNSTotal Voting Rights
27th Jul 20234:11 pmRNSTransaction in Own Shares
24th Jul 20232:00 pmRNSNet Asset Value(s)
3rd Jul 202311:26 amRNSTotal Voting Rights
20th Jun 20233:45 pmRNSTransaction in Own Shares
13th Jun 20237:00 amRNSHalf-yearly Report
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.